Related Experiment Video

Updated: Aug 6, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

A model for estimating individualized valproate clearance values in children

J H Botha1, A L Gray, R Miller

  • 1Department of Clinical and Experimental Pharmacology, University of Natal, South Africa.

Journal of Clinical Pharmacology
|October 1, 1995
PubMed

Insights

Population pharmacokinetics of valproic acid in children were evaluated. Valproic acid clearance decreased with age, and was higher with carbamazepine, impacting epilepsy treatment dosing.

Area of Science:

  • Pharmacokinetics
  • Pediatric Epilepsy
  • Drug Metabolism

Background:

  • Valproic acid is a common antiepileptic drug in children.
  • Understanding its population pharmacokinetics is crucial for optimizing therapeutic drug monitoring.
  • Concomitant medications can influence valproic acid levels.

Purpose of the Study:

  • To characterize the population pharmacokinetics of valproic acid in pediatric epilepsy patients.
  • To identify factors influencing valproic acid clearance, such as weight, age, and co-medications.

Main Methods:

  • Utilized 97 steady-state serum valproate concentrations from 52 children (1.2-16 years).
  • Employed a one-compartment model fitted with the Nonlinear Mixed Effects Model (NONMEM).
  • Analyzed data from patients on valproate monotherapy and those with concomitant antiepileptic drugs.

Main Results:

  • Valproic acid clearance (CL) was modeled as CL = [EXP(0.022WT-1.38)] x M, where WT is weight and M is a medication scaling factor.
  • M was 1 for monotherapy and 1.61 for carbamazepine; phenytoin and phenobarbitone effects were not statistically significant.
  • Weight-adjusted valproate clearance decreased with increasing age.

Conclusions:

  • Pediatric valproic acid clearance is influenced by weight, age, and carbamazepine co-administration.
  • The findings provide valuable data for refining valproic acid dosing strategies in children.
  • Further studies are needed to confirm the impact of phenytoin and phenobarbitone on valproic acid clearance.

More Related Videos

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

Development and Standardization of an Ex Vivo Micromethod for Intracellular Quantification of Vincristine in Primary ALL Cells by LC-MS/MS08:24

Development and Standardization of an Ex Vivo Micromethod for Intracellular Quantification of Vincristine in Primary ALL Cells by LC-MS/MS

Published on: January 23, 2026

Related Concept Videos

Clearance Models: Compartment Models01:25

Clearance Models: Compartment Models

Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume of...
Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated from...
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...